A detailed history of Abrdn PLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Abrdn PLC holds 1,972,242 shares of AMLX stock, worth $9.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,972,242
Previous 118,247 1567.9%
Holding current value
$9.78 Million
Previous $224,000 2752.68%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$1.65 - $3.24 $3.06 Million - $6.01 Million
1,853,995 Added 1567.9%
1,972,242 $6.39 Million
Q1 2024

May 08, 2024

SELL
$2.71 - $19.57 $209,336 - $1.51 Million
-77,246 Reduced 39.51%
118,247 $335,000
Q4 2023

Jan 31, 2024

BUY
$12.07 - $18.46 $2.36 Million - $3.61 Million
195,493 New
195,493 $2.88 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.